KRT12 (Keratin, type I cytoskeletal 12) variants and mutations
KRT12 (also known as Keratin, type I cytoskeletal 12) is a human protein-coding gene encoding a keratin, type I cytoskeletal 12 protein. It pairs with keratin 3 to form the characteristic intermediate-filament network of corneal epithelial cells. Dominant pathogenic variants cause Meesmann corneal dystrophy, with epithelial microcysts, irritation, and variable visual symptoms. This analysis covers 859 KRT12 variants and mutations. Of these, 80% have computational variant effect predictions. Disease context includes Meesmann corneal dystrophy, hereditary disease, and posterior polymorphous corneal dystrophy. Example KRT12 variants include M1?, D2G, and D2V.
Variant analysis overview
- Gene: KRT12
- Protein: Keratin, type I cytoskeletal 12
- UniProt accession: Q99456
- Organism: Homo sapiens
- Variants analyzed: 859
- Variant scope: all variants
- Completed: 2026-08-22
Variant and mutation evidence
- Variant composition: 600 unspecified-consequence records; 1 stop retained variant; 125 missense variants; 104 synonymous variants; 9 stop-gained variants; 14 frameshift variants; 3 splice-region variants; 3 in-frame deletions; 2 substitution
- Prediction scores: 684 variants have prediction scores (80% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Meesmann corneal dystrophy, hereditary disease, posterior polymorphous corneal dystrophy, X-linked corneal dermoid, Fuchs endothelial corneal dystrophy, Thiel-Behnke corneal dystrophy, X-linked endothelial corneal dystrophy, Peters anomaly, Familial ocular anterior segment mesenchymal dysgenesis, lattice corneal dystrophy type I, macular corneal dystrophy, retinitis pigmentosa.
Protein structure and variant hotspots
- Protein features: 1 domains.
- Structural context: 584 variants have structural context.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable KRT12 variants
Examples include M1?, D2G, D2V, N5K, N5S, N6D, N6K, N6T. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- D2G (p.Asp2Gly), ExAC rs772315405, gnomAD rs772315405, REVEL 0.16, CADD 15.60
- D2V (p.Asp2Val), ExAC rs772315405, gnomAD rs772315405, REVEL 0.21, CADD 15.00
- N5K (p.Asn5Lys), gnomAD rs1183532728, REVEL 0.14, CADD 0.08
- N5S (p.Asn5Ser), Ensembl rs1597844607, REVEL 0.11, CADD 0.05
- N6D (p.Asn6Asp), TOPMed rs1907065474, REVEL 0.11, CADD 5.33
- N6K (p.Asn6Lys), ExAC rs748192066, gnomAD rs748192066, REVEL 0.15, CADD 12.50
- N6T (p.Asn6Thr), TOPMed rs1473405391, gnomAD rs1473405391, REVEL 0.13, CADD 4.83
- T7N (p.Thr7Asn), gnomAD rs1201788608, REVEL 0.15, CADD 3.85
- M8I (p.Met8Ile), gnomAD rs1433191683, REVEL 0.31, CADD 19.40
- M8T (p.Met8Thr), TOPMed rs1907064754
- S9* (p.Ser9Ter), ExAC rs780056598, TOPMed rs780056598, gnomAD rs780056598, CADD 35.00
- S9L (p.Ser9Leu), NCI-TCGA Cosmic COSV5242, REVEL 0.30, CADD 17.60, Variant assessed as somatic; moderate impact.
- S11P (p.Ser11Pro), Ensembl rs1567743771, REVEL 0.48, CADD 24.20
- V12L (p.Val12Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R13C (p.Arg13Cys), ExAC rs745817473, TOPMed rs745817473, gnomAD rs745817473, REVEL 0.16, CADD 11.00
- R13H (p.Arg13His), rs765618473, ExAC rs765618473, TOPMed rs765618473, gnomAD rs765618473, REVEL 0.14, CADD 8.17, Variant assessed as somatic; moderate impact.
- R13L (p.Arg13Leu), ExAC rs765618473, TOPMed rs765618473, gnomAD rs765618473
- R13P (p.Arg13Pro), ExAC rs765618473, TOPMed rs765618473, gnomAD rs765618473, REVEL 0.14, CADD 8.69
- R13S (p.Arg13Ser), ExAC rs745817473, TOPMed rs745817473, gnomAD rs745817473, REVEL 0.14, CADD 8.00, Uncertain significance, Inborn genetic diseases
- T14N (p.Thr14Asn), ExAC rs751254737, gnomAD rs751254737
- P15S (p.Pro15Ser), rs11650915, ClinGen CA216518, ClinVar RCV000056428, ClinVar RCV001730494, REVEL 0.09, CADD 0.20, Benign, not provided; Corneal dystrophy, Meesmann, 1
- G16R (p.Gly16Arg), ExAC rs752143093, TOPMed rs752143093, gnomAD rs752143093, REVEL 0.24, CADD 18.40
- L17P (p.Leu17Pro), TOPMed rs1907062665, REVEL 0.14, CADD 8.58
- S18C (p.Ser18Cys), TOPMed rs971553130
- S18F (p.Ser18Phe), rs971553130, TOPMed rs971553130, NCI-TCGA Cosmic COSV9928, Variant assessed as somatic; moderate impact.
- S18T (p.Ser18Thr), NCI-TCGA Cosmic COSV9928, Variant assessed as somatic; moderate impact.
- R19G (p.Arg19Gly), 1000Genomes rs200258980, ExAC rs200258980, TOPMed rs200258980, gnomAD rs200258980, REVEL 0.13, CADD 15.50
- R19Q (p.Arg19Gln), rs1308897791, gnomAD rs1308897791, REVEL 0.13, CADD 7.20, Likely benign, Inborn genetic diseases
- R19W (p.Arg19Trp), rs200258980, 1000Genomes rs200258980, ExAC rs200258980, TOPMed rs200258980, not provided
- R20L (p.Arg20Leu), ExAC rs766699655, TOPMed rs766699655, gnomAD rs766699655, REVEL 0.21, CADD 15.30
- R20Q (p.Arg20Gln), ExAC rs766699655, TOPMed rs766699655, gnomAD rs766699655, REVEL 0.10, CADD 10.30
- R20W (p.Arg20Trp), rs17566772, ClinGen CA8548971, ClinVar RCV002104715, UniProt VAR 009547, REVEL 0.12, CADD 15.70, Benign, not provided
- L21I (p.Leu21Ile), gnomAD rs1406502047, REVEL 0.12, CADD 8.09
- L21V (p.Leu21Val), gnomAD rs1406502047
- S23T (p.Ser23Thr), gnomAD rs1416567493, REVEL 0.12, CADD 4.80
- S23W (p.Ser23Trp), NCI-TCGA Cosmic COSV5242, Variant assessed as somatic; moderate impact.
- Q24K (p.Gln24Lys), rs1469212401, gnomAD rs1469212401, REVEL 0.25, CADD 22.40, Variant assessed as somatic; moderate impact.
- S25I (p.Ser25Ile), 1000Genomes rs537683583, gnomAD rs537683583, REVEL 0.23, CADD 14.60
- S25N (p.Ser25Asn), 1000Genomes rs537683583, gnomAD rs537683583, REVEL 0.10, CADD 7.00
- S25R (p.Ser25Arg), gnomAD rs1251827411, REVEL 0.43, CADD 1.56
- I27T (p.Ile27Thr), NCI-TCGA Cosmic COSV5243, Variant assessed as somatic; moderate impact.
- G28C (p.Gly28Cys), NCI-TCGA Cosmic COSV5243, Variant assessed as somatic; moderate impact.
- G28D (p.Gly28Asp), Ensembl rs909101576, REVEL 0.27, CADD 22.40
- R29T (p.Arg29Thr), TOPMed rs1179842203
- P30S (p.Pro30Ser), TOPMed rs1907060179, REVEL 0.19, CADD 15.00
- R31G (p.Arg31Gly), 1000Genomes rs367803772, ESP rs367803772, ExAC rs367803772, gnomAD rs367803772, REVEL 0.15, CADD 15.90
- R31K (p.Arg31Lys), ESP rs370150894, ExAC rs370150894, TOPMed rs370150894, gnomAD rs370150894, REVEL 0.20, CADD 14.70, Uncertain significance, Inborn genetic diseases
- R31W (p.Arg31Trp), 1000Genomes rs367803772, ESP rs367803772, ExAC rs367803772, gnomAD rs367803772
- G32D (p.Gly32Asp), ExAC rs774365265, gnomAD rs774365265, REVEL 0.30, CADD 21.40
- M33I (p.Met33Ile), ExAC rs745841591, gnomAD rs745841591, REVEL 0.23, CADD 11.80
- M33L (p.Met33Leu), ExAC rs768771627, TOPMed rs768771627, gnomAD rs768771627, REVEL 0.24, CADD 12.60
- S34P (p.Ser34Pro), rs781154839, ExAC rs781154839, TOPMed rs781154839, ClinGen CA8548962, Uncertain significance, Inborn genetic diseases
- A35P (p.Ala35Pro), rs1289055689, ClinGen CA399389513, ClinVar RCV003362020, TOPMed rs1289055689, REVEL 0.38, CADD 18.30, Uncertain significance, Inborn genetic diseases
- A35V (p.Ala35Val), gnomAD rs1411984667, REVEL 0.23, CADD 20.30
- S37C (p.Ser37Cys), gnomAD rs1249779228
- S37G (p.Ser37Gly), gnomAD rs1249779228, REVEL 0.12, CADD 17.40
- S37N (p.Ser37Asn), ExAC rs770746017, gnomAD rs770746017, REVEL 0.14, CADD 17.40
- S37R (p.Ser37Arg), TOPMed rs1302976723, gnomAD rs1302976723, REVEL 0.24, CADD 10.50, Uncertain significance, Inborn genetic diseases
- V38I (p.Val38Ile), ExAC rs746755967, TOPMed rs746755967, gnomAD rs746755967, REVEL 0.13, CADD 3.57
- V38L (p.Val38Leu), ExAC rs746755967, TOPMed rs746755967, gnomAD rs746755967, REVEL 0.17, CADD 3.42
- G41S (p.Gly41Ser), NCI-TCGA Cosmic COSV5243, Variant assessed as somatic; moderate impact.
- G43A (p.Gly43Ala), ExAC rs747832228, gnomAD rs747832228, REVEL 0.13, CADD 4.92
- G43R (p.Gly43Arg), 1000Genomes rs548422937, ExAC rs548422937, TOPMed rs548422937, gnomAD rs548422937, REVEL 0.34, CADD 15.60, Uncertain significance, Inborn genetic diseases
- G44R (p.Gly44Arg), 1000Genomes rs146312988, ESP rs146312988, ExAC rs146312988, TOPMed rs146312988, REVEL 0.34, CADD 23.30
- S45C (p.Ser45Cys), TOPMed rs1907057490, Uncertain significance, Inborn genetic diseases
- S45N (p.Ser45Asn), TOPMed rs1267702304, gnomAD rs1267702304, REVEL 0.18, CADD 4.04
- A46T (p.Ala46Thr), ExAC rs754340055, gnomAD rs754340055, REVEL 0.10, CADD 1.29
- F47S (p.Phe47Ser), ExAC rs756563164, gnomAD rs756563164
- A51T (p.Ala51Thr), Ensembl rs2143270943
- S52N (p.Ser52Asn), gnomAD rs1214997129, REVEL 0.09, CADD 7.22
- G54A (p.Gly54Ala), ExAC rs774610996, gnomAD rs774610996, REVEL 0.20, CADD 10.20
- G54E (p.Gly54Glu), ExAC rs774610996, gnomAD rs774610996, REVEL 0.32, CADD 16.90
- G54R (p.Gly54Arg), rs141949869, 1000Genomes rs141949869, ESP rs141949869, ExAC rs141949869, REVEL 0.25, CADD 16.10, Benign, KRT12-related disorder
- G54W (p.Gly54Trp), 1000Genomes rs141949869, ESP rs141949869, ExAC rs141949869, TOPMed rs141949869, REVEL 0.34, CADD 23.30, Benign
- G55R (p.Gly55Arg), ESP rs371259068, ExAC rs371259068, TOPMed rs371259068, gnomAD rs371259068, REVEL 0.33, CADD 23.10
- G56C (p.Gly56Cys), TOPMed rs1321447707, gnomAD rs1321447707
- G56S (p.Gly56Ser), TOPMed rs1321447707, gnomAD rs1321447707, REVEL 0.19, CADD 13.60
- F57V (p.Phe57Val), gnomAD rs1282922358, REVEL 0.38, CADD 14.70
- S58A (p.Ser58Ala), ExAC rs763049820, gnomAD rs763049820, REVEL 0.14, CADD 16.70
- S58F (p.Ser58Phe), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A59T (p.Ala59Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A60S (p.Ala60Ser), Ensembl rs2143270838
- S61C (p.Ser61Cys), TOPMed rs1907055673
- M62I (p.Met62Ile), gnomAD rs998041365, REVEL 0.28, CADD 20.80
- M62V (p.Met62Val), ExAC rs770795118, REVEL 0.33, CADD 15.30
- F63L (p.Phe63Leu), TOPMed rs1597844328, REVEL 0.21, CADD 16.20
- S66N (p.Ser66Asn), 1000Genomes rs202056647, ExAC rs202056647, TOPMed rs202056647, gnomAD rs202056647
- S66R (p.Ser66Arg), Ensembl rs1567743376, REVEL 0.41, CADD 11.30
- S66T (p.Ser66Thr), 1000Genomes rs202056647, ExAC rs202056647, TOPMed rs202056647, gnomAD rs202056647, REVEL 0.18, CADD 12.70
- S67Y (p.Ser67Tyr), Ensembl rs2143270772
- G68D (p.Gly68Asp), NCI-TCGA Cosmic COSV9928, Variant assessed as somatic; moderate impact.
- G68S (p.Gly68Ser), TOPMed rs1322024236, gnomAD rs1322024236, REVEL 0.23, CADD 20.30
- G70E (p.Gly70Glu), TOPMed rs1427940484, gnomAD rs1427940484, REVEL 0.32, CADD 22.40
- G70R (p.Gly70Arg), gnomAD rs1467795002, REVEL 0.20, CADD 15.60
- G70V (p.Gly70Val), TOPMed rs1427940484, gnomAD rs1427940484, REVEL 0.37, CADD 22.50
- G70W (p.Gly70Trp), gnomAD rs1467795002, REVEL 0.36, CADD 22.40
- G71A (p.Gly71Ala), ExAC rs771841418, TOPMed rs771841418, gnomAD rs771841418
- G71C (p.Gly71Cys), TOPMed rs1176336411, gnomAD rs1176336411, REVEL 0.31, CADD 23.30, Uncertain significance, Inborn genetic diseases
- G71D (p.Gly71Asp), rs771841418, ExAC rs771841418, TOPMed rs771841418, gnomAD rs771841418, Variant assessed as somatic; moderate impact.
- G71V (p.Gly71Val), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- G72W (p.Gly72Trp), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- G74R (p.Gly74Arg), ESP rs138169839, ExAC rs138169839, TOPMed rs138169839, gnomAD rs138169839, REVEL 0.26, CADD 8.10
- G74V (p.Gly74Val), gnomAD rs1450062310, REVEL 0.15, CADD 2.19
- S75I (p.Ser75Ile), ExAC rs771057394, TOPMed rs771057394, gnomAD rs771057394, REVEL 0.14, CADD 7.11
- S75R (p.Ser75Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S76C (p.Ser76Cys), ExAC rs748781010, gnomAD rs748781010, REVEL 0.11, CADD 8.89
- M77T (p.Met77Thr), gnomAD rs1211162885, REVEL 0.17, CADD 7.07
- M77V (p.Met77Val), TOPMed rs1255431749, gnomAD rs1255431749, REVEL 0.19, CADD 0.34
- A78T (p.Ala78Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G79E (p.Gly79Glu), NCI-TCGA Cosmic COSV5243, Variant assessed as somatic; moderate impact.
- G79V (p.Gly79Val), gnomAD rs1314156665, REVEL 0.49, CADD 19.80
- G82D (p.Gly82Asp), TOPMed rs946841672, REVEL 0.53, CADD 22.90
- A83V (p.Ala83Val), TOPMed rs1394071769, gnomAD rs1394071769, REVEL 0.19, CADD 4.66
- G84A (p.Gly84Ala), ExAC rs756755206, TOPMed rs756755206, gnomAD rs756755206, REVEL 0.13, CADD 8.86
- G84C (p.Gly84Cys), Ensembl rs2143270595
- G84V (p.Gly84Val), ExAC rs756755206, TOPMed rs756755206, gnomAD rs756755206, REVEL 0.21, CADD 15.20
- Y85C (p.Tyr85Cys), Ensembl rs1907051811
- A88V (p.Ala88Val), rs999519108, NCI-TCGA Cosmic COSV5243, TOPMed rs999519108, gnomAD rs999519108, REVEL 0.13, CADD 13.90, Variant assessed as somatic; moderate impact.
- L89P (p.Leu89Pro), TOPMed rs1451011108, gnomAD rs1451011108, REVEL 0.16, CADD 16.10
- G90S (p.Gly90Ser), ExAC rs750956829, gnomAD rs750956829, REVEL 0.28, CADD 22.10
- G91E (p.Gly91Glu), NCI-TCGA Cosmic COSV9928, REVEL 0.23, CADD 17.50, Variant assessed as somatic; moderate impact.
- G91R (p.Gly91Arg), TOPMed rs1365790500
- S93R (p.Ser93Arg), 1000Genomes rs532861831, ExAC rs532861831, gnomAD rs532861831, REVEL 0.20, CADD 7.87
- G95E (p.Gly95Glu), gnomAD rs1466249729, REVEL 0.38, CADD 22.10
- M99I (p.Met99Ile), 1000Genomes rs144158374
- M99L (p.Met99Leu), ExAC rs765295249, TOPMed rs765295249, gnomAD rs765295249, REVEL 0.13, CADD 0.20
- G100R (p.Gly100Arg), ExAC rs760663730, gnomAD rs760663730, REVEL 0.32, CADD 18.90
- F101C (p.Phe101Cys), ESP rs150377929, ExAC rs150377929, TOPMed rs150377929, gnomAD rs150377929, REVEL 0.26, CADD 19.90
- F101L (p.Phe101Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- F101S (p.Phe101Ser), ESP rs150377929, ExAC rs150377929, TOPMed rs150377929, gnomAD rs150377929, REVEL 0.15, CADD 15.30
- G102E (p.Gly102Glu), TOPMed rs1907049106, gnomAD rs1907049106, REVEL 0.29, CADD 10.30
- G103D (p.Gly103Asp), ExAC rs773895186, gnomAD rs773895186, REVEL 0.39, CADD 16.50
- S104N (p.Ser104Asn), 1000Genomes rs201147294, ExAC rs201147294, TOPMed rs201147294, gnomAD rs201147294, REVEL 0.16, CADD 4.35
- P105S (p.Pro105Ser), Ensembl rs1907048616
- G106A (p.Gly106Ala), ExAC rs748892293, TOPMed rs748892293, gnomAD rs748892293, REVEL 0.17, CADD 5.36
- S109F (p.Ser109Phe), gnomAD rs866275199, REVEL 0.14, CADD 14.40
- G111C (p.Gly111Cys), ExAC rs779771822, TOPMed rs779771822, gnomAD rs779771822, REVEL 0.11, CADD 8.45
- G111D (p.Gly111Asp), NCI-TCGA Cosmic COSV9928, TOPMed rs1907047913, Variant assessed as somatic; moderate impact.
- S114* (p.Ser114Ter), ExAC rs746417734, TOPMed rs746417734, gnomAD rs746417734, CADD 33.00
- S114L (p.Ser114Leu), ExAC rs746417734, TOPMed rs746417734, gnomAD rs746417734, REVEL 0.11, CADD 14.90, Uncertain significance, Inborn genetic diseases
- D117N (p.Asp117Asn), rs757586930, NCI-TCGA Cosmic COSV9928, ExAC rs757586930, gnomAD rs757586930, REVEL 0.24, CADD 20.50, Variant assessed as somatic; moderate impact.
- D117Y (p.Asp117Tyr), ExAC rs757586930, gnomAD rs757586930, REVEL 0.18, CADD 19.30
- G118* (p.Gly118Ter), gnomAD rs1297258501, CADD 34.00
- G118E (p.Gly118Glu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G119C (p.Gly119Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G119D (p.Gly119Asp), ExAC rs751895683, TOPMed rs751895683, gnomAD rs751895683, REVEL 0.27, CADD 19.50
- L121P (p.Leu121Pro), TOPMed rs1161224382, gnomAD rs1161224382, REVEL 0.50, CADD 24.30
- S122P (p.Ser122Pro), ExAC rs777860918, gnomAD rs777860918, REVEL 0.43, CADD 21.50
- G123A (p.Gly123Ala), ExAC rs758712817, TOPMed rs758712817, gnomAD rs758712817, REVEL 0.27, CADD 20.50
- G123R (p.Gly123Arg), Ensembl rs1907046117
- S124* (p.Ser124Ter), ExAC rs752901553, gnomAD rs752901553, CADD 34.00
- E125Q (p.Glu125Gln), ExAC rs765346056, gnomAD rs765346056, REVEL 0.77, CADD 23.60
- E125V (p.Glu125Val), NCI-TCGA Cosmic COSV5243, Variant assessed as somatic; moderate impact.
- K126N (p.Lys126Asn), Ensembl rs1012372008
- E127* (p.Glu127Ter), NCI-TCGA Cosmic COSV5242, CADD 34.00, Variant assessed as somatic; high impact.
- E127D (p.Glu127Asp), TOPMed rs1232158974, gnomAD rs1232158974, REVEL 0.46, CADD 21.20
- T128A (p.Thr128Ala), rs149532038, 1000Genomes rs149532038, ExAC rs149532038, TOPMed rs149532038, REVEL 0.70, CADD 23.80, Conflicting interpretations, not provided; Inborn genetic diseases
- T128N (p.Thr128Asn), NCI-TCGA Cosmic COSV9928, Variant assessed as somatic; moderate impact.
- M129I (p.Met129Ile), NCI-TCGA Cosmic COSV5243, TOPMed rs1907044910, Variant assessed as somatic; moderate impact., in MECD1
- M129T (p.Met129Thr), rs28936695, ClinGen CA119163, ClinVar RCV000008389, ClinVar RCV000056417, Pathogenic, not provided
- M129V (p.Met129Val), rs267607387, ClinGen CA216511, ClinVar RCV000056416, ClinVar RCV000623893, Pathogenic/Likely pathogenic, not provided; Inborn genetic diseases
- Q130P (p.Gln130Pro), rs58864803, ClinGen CA216512, ClinVar RCV000056418, UniProt VAR 013127, not provided
- N131D (p.Asn131Asp), ExAC rs750390805, gnomAD rs750390805
- L132P (p.Leu132Pro), rs886038212, ClinGen CA10586701, ClinVar RCV000252858, UniProt VAR 072070, Pathogenic, Corneal dystrophy, Meesmann, 1
- L132V (p.Leu132Val), UniProt VAR 083313, Pathogenic, in MECD1
- N133D (p.Asn133Asp), NCI-TCGA Cosmic COSV5243, Variant assessed as somatic; moderate impact.
- N133K (p.Asn133Lys), rs61167390, Ensembl rs61167390, ClinGen CA216513, ClinVar RCV000056419, Likely pathogenic, not provided
- R135G (p.Arg135Gly), rs58410481, Ensembl rs58410481, ClinGen CA119159, ClinVar RCV000008385, Pathogenic, Corneal dystrophy, Meesmann, 1
- R135I (p.Arg135Ile), rs57218384, Ensembl rs57218384, ClinGen CA119160, ClinVar RCV000008386, Pathogenic, Corneal dystrophy, Meesmann, 1
- R135S (p.Arg135Ser), rs61282718, ClinGen CA216515, ClinVar RCV000056423, UniProt VAR 031394, not provided
- R135T (p.Arg135Thr), rs57218384, ClinGen CA119157, ClinVar RCV000008383, ClinVar RCV000056421, Pathogenic, Corneal dystrophy, Meesmann, 1
- L136* (p.Leu136Ter), ExAC rs761525290, TOPMed rs761525290, gnomAD rs761525290, CADD 36.00
- A137P (p.Ala137Pro), rs58038639, Ensembl rs58038639, ClinGen CA216516, ClinVar RCV000056424, not provided
- L140M (p.Leu140Met), ExAC rs762716157, gnomAD rs762716157
- L140Q (p.Leu140Gln), UniProt VAR 072071, Pathogenic, in MECD1
- L140R (p.Leu140Arg), rs58918655, Ensembl rs58918655, ClinGen CA119162, ClinVar RCV000008388, Pathogenic, Corneal dystrophy, Meesmann, 1
- D141H (p.Asp141His), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- D141N (p.Asp141Asn), ExAC rs775252087, gnomAD rs775252087, REVEL 0.42, CADD 22.10
- D141Y (p.Asp141Tyr), ExAC rs775252087, gnomAD rs775252087, REVEL 0.59, CADD 23.70
Public KRT12 analysis runs
- KRT12 analysis run — KRT12 (859 variants) — completed 2026-08-22